Nanofarma Development Overview
- Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Nanofarma Development General Information
Description
Provider of drug development services. The company specializes in oral drug delivery systems based on nanotechnology. The system is a microcontainers made from specially degradable biopolymers, which have the ability to attach to specified parts of the gastrointestinal tract and protect the active ingredient from the destructive action of proteolytic enzymes.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Izvarino Pharma
Primary Office
- Vosstaniya ulitsa 100
- Kazan, 420095
- Russia
Nanofarma Development Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanofarma Development Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nanofarma Development Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|